4,5,5-Trimethylhexanoic acid | 94349-37-8

• 分子结构分类: 有机化合物 - 脂质和类脂质分子 - 脂肪酰基
• 英文名称: 4,5,5-Trimethylhexanoic acid
• CAS: 94349-37-8
• 化学式: C₉H₁₈O₂
• 分子量: 158.24
• InChiKey: UKVTYBBTYKPUSB-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.6
• 重原子数：
  11
• 可旋转键数：
  4
• 环数：
  0.0
• sp3杂化的碳原子比例：
  0.89
• 拓扑面积：
  37.3
• 氢给体数：
  1
• 氢受体数：
  2

文献信息

• NITROGEN-CONTAINING COMPOUNDS SUITABLE FOR USE IN THE PRODUCTION OF POLYURETHANES
  申请人：Evonik Degussa GmbH

  公开号：US20180194889A1

  公开（公告）日：2018-07-12

  The present invention provides for the use of nitrogen compounds of formula (I) and/or of corresponding quaternized and/or protonated compounds for production of polyurethanes, compositions containing these compounds and polyurethane systems, especially polyurethane foams, which have been obtained using the compounds.

  本发明提供了使用式(I)的氮化合物和/或相应的季铵化和/或质子化化合物用于生产聚氨酯、含有这些化合物的组合物和聚氨酯体系的方法，特别是使用这些化合物获得的聚氨酯泡沫。
• Novel peptides as NS3-serine protease inhibitors of hepatitis C virus
  申请人：Saksena K. Anil

  公开号：US20070032433A1

  公开（公告）日：2007-02-08

  The present invention discloses novel compounds which have HCV protease inhibitory activity as well as methods for preparing such compounds. In another embodiment, the invention discloses pharmaceutical compositions comprising such compounds as well as methods of using them to treat disorders associated with the HCV protease.

  本发明揭示了具有HCV蛋白酶抑制活性的新化合物，以及制备这些化合物的方法。在另一种实施方式中，本发明揭示了包含这些化合物的药物组合物，以及使用它们治疗与HCV蛋白酶相关的疾病的方法。
• OXAZOLE PYRIDINE DERIVATIVES USEFUL AS S1P1 RECEPTOR AGONISTS
  申请人：Quattropani Anna

  公开号：US20110306636A1

  公开（公告）日：2011-12-15

  The present invention provides oxadiazole pyridine derivatives of Formula (I), their use as medicaments and their use for treating multiple sclerosis and other diseases.

  本发明提供了式（I）的噁唑吡啶衍生物，其用作药物治疗多发性硬化症和其他疾病。
• NOVEL PEPTIDES AS NS3-SERINE PROTEASE INHIBITORS OF HEPATITIS C VIRUS
  申请人：Saksena Anil K.

  公开号：US20110117057A1

  公开（公告）日：2011-05-19

  The present invention discloses novel compounds which have HCV protease inhibitory activity as well as methods for preparing such compounds. In another embodiment, the invention discloses pharmaceutical compositions comprising such compounds as well as methods of using them to treat disorders associated with the HCV protease.

  本发明披露了具有HCV蛋白酶抑制活性的新化合物，以及制备这些化合物的方法。在另一种实施方式中，本发明披露了包含这些化合物的制药组合物，以及使用它们治疗与HCV蛋白酶相关的疾病的方法。
• Refrigeration lubricant composition
  申请人：NOF CORPORATION

  公开号：EP1533363A1

  公开（公告）日：2005-05-25

  The present invention provides a refrigeration lubricant composition comprises an ester obtained from a mixed alcohol and a mixed carboxylic acid as a main component. The mixed alcohol comprises 65 to 99.95 mol% of pentaerythritol and 0.05 to 35 mol% of dipentaerythritol, the mixed carboxylic acid comprises 25 to 55 mol% of monocarboxylic acid having 5 to 8 carbon atoms and 45 to 75 mol% of isononanoic acid, and the composition has a hydroxyl value of 5.0 mgKOH/g or less and an acid value of 0.05 mgKOH/g or less.

  本发明提供了一种冷冻润滑剂组合物，其主要成分是由混合醇和混合羧酸制成的酯。混合醇包括 65 至 99.95 摩尔%的季戊四醇和 0.05 至 35 摩尔%的二季戊四醇，混合羧酸包括 25 至 55 摩尔%的具有 5 至 8 个碳原子的单羧酸和 45 至 75 摩尔%的异壬酸，该组合物的羟值为 5.0 mgKOH/g 或更低，酸值为 0.05 mgKOH/g 或更低。